Benjamin Harshbarger Insider Trading
Get free email notifications about insider trading for Benjamin Harshbarger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Benjamin Harshbarger. Benjamin Harshbarger is a General Counsel in NOVELION THERAPEUTICS INC. ($QLTI) and a General Counsel and Secretary in QLT INC/BC ($QLTI) and a See Remarks in NOVELION THERAPEUTICS INC. ($NVLN) and a Acting General Counsel in Aegerion Pharmaceuticals, Inc. ($AEGR) and a General Counsel in Aegerion Pharmaceuticals, Inc. ($AEGR) and a General Counsel and Secretary in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Secretary and General Counsel in CATABASIS PHARMACEUTICALS INC ($CATB).
Address: C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE 02142 MA
Companies in which Benjamin Harshbarger is an Insider
Aegerion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Benjamin Harshbarger: Acting General Counsel, General Counsel and Secretary
Holdings: 0 shares
Latest Transaction: Nov 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATABASIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Benjamin Harshbarger: Secretary and General Counsel
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 12 2020
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Benjamin Harshbarger: See Remarks, General Counsel and Secretary
Holdings: 3,683 shares
Latest Transaction: May 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Benjamin Harshbarger
Sentiment: All, AEGR, CATB, NVLN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | Harshbarger Benjamin | Secretary and Gener ... | Option Exercise | A | 6.17 | 45,000 | 277,650 | 45,000 | |
| May 13 2019 | NVLN | NOVELION THERAPEUT ... | Harshbarger Benjamin | See Remarks | Payment of Exercise | F | 1.22 | 212 | 259 | 3,683 | 3.9 K to 3.7 K (-5.44 %) |
| Nov 05 2018 | NVLN | NOVELION THERAPEUT ... | Harshbarger Benjamin | General Counsel | Payment of Exercise | F | 3.94 | 98 | 386 | 3,895 | 4 K to 3.9 K (-2.45 %) |
| Nov 05 2018 | NVLN | NOVELION THERAPEUT ... | Harshbarger Benjamin | General Counsel | Payment of Exercise | F | 4.15 | 150 | 623 | 3,993 | 4.1 K to 4 K (-3.62 %) |
| Nov 05 2018 | NVLN | NOVELION THERAPEUT ... | Harshbarger Benjamin | General Counsel | Payment of Exercise | F | 4.26 | 322 | 1,372 | 4,143 | 4.5 K to 4.1 K (-7.21 %) |
| Apr 03 2018 | NVLN | NOVELION THERAPEUT ... | Harshbarger Benjamin | General Counsel | Payment of Exercise | F | 3.50 | 52 | 182 | 4,465 | 4.5 K to 4.5 K (-1.15 %) |
| Feb 14 2018 | QLTI | NOVELION THERAPEUT ... | Harshbarger Benjamin | General Counsel | Option Exercise | A | 4.44 | 45,000 | 199,800 | 45,000 |